Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort

Abstract

Low maternal plasma viral load is the key factor for preventing MTCT. Benefits in terms of MTCT reduction may be expected from early antiretroviral prophylaxis. The potential toxicity of prolonged antiretroviral use in pregnancy should be evaluated.